Skip to main content
Kindstar Globalgene Technology, Inc. logo

Kindstar Globalgene Technology, Inc. — Investor Relations & Filings

Ticker · 9960 ISIN · KYG5262E1044 HKEX Human health and social work activities
Open in API
Filings indexed 603 across all filing types
Latest filing 2022-12-20 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 9960

About Kindstar Globalgene Technology, Inc.

http://www.kindstar.com.cn

Kindstar Globalgene Technology, Inc. is a leading independent provider of advanced specialty clinical testing services, specializing in esoteric testing. The company maintains the largest esoteric testing portfolio in its market, utilizing internationally-advanced laboratory facilities for clinical testing, scientific research, and applied R&D. Its comprehensive testing menu, featuring over 100 items, covers critical diagnostic areas including hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology. These services provide physicians and patients access to specialized diagnostics crucial for the diagnosis and treatment of major diseases.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, referencing compliance with listing rules of the Hong Kong Stock Exchange. The content is focused on reporting share repurchase transactions and changes in issued share capital, not on financial results, management commentary, or other report types. This matches the definition of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2022-12-20 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, referencing compliance with listing rules of the Hong Kong Stock Exchange. The content is focused on reporting share repurchase activities and changes in issued shares, not on financial results, management changes, or other report types. This matches the description of a Transaction in Own Shares filing, which reports company buybacks or sales of its own shares. The document is lengthy (15,000 characters) and contains substantive data, so it is not a mere announcement or certification. Therefore, the correct classification is POS (Transaction in Own Shares).
2022-12-19 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, referencing compliance with listing rules of the Hong Kong Stock Exchange. The content is a regulatory disclosure of share repurchase activity rather than a financial report or earnings release. It is not an announcement of a report publication but a formal regulatory filing about share capital changes. This fits the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares.
2022-12-16 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and pertains to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It includes detailed tables of repurchase of shares with dates and quantities, referencing compliance with listing rules of the Hong Kong Stock Exchange. The content is focused on reporting share repurchase transactions and changes in issued shares, not on financial results, management commentary, or other report types. This matches the description of a 'Transaction in Own Shares' filing, which reports company buybacks or sales of its own shares. The document length is substantial and contains detailed transactional data, confirming it is the report itself, not just an announcement. Therefore, the correct classification is POS (Transaction in Own Shares).
2022-12-15 English
Next Day Disclosure Returns
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued share capital and share buybacks for Kindstar Globalgene Technology, Inc. It contains detailed data on repurchases of shares over multiple dates, including quantities and percentages. The document references compliance with listing rules of the Hong Kong Stock Exchange and includes confirmations about authorization and legal compliance related to share issues and repurchases. There is no indication of financial statements, earnings data, management discussion, or other report types. The content is focused on reporting transactions in the company's own shares (share buybacks). Therefore, the document fits the category of 'Transaction in Own Shares' (POS). The document length is substantial and contains detailed transactional data, supporting a high confidence in classification.
2022-12-14 English
PROPOSED ADOPTION OF THE TENTH AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed adoption of the tenth amended and restated memorandum and articles of association (M&AA) of the company. It discusses changes to the company's constitutional documents and states that the amendments will be subject to shareholder approval at the forthcoming AGM. The document is an announcement of a governance-related proposal and does not contain actual financial data or detailed governance reports. It is not a full governance report (CGR) but rather an announcement about governance changes to be voted on. The document is also relatively short (3893 characters) and serves as a notice of a proposal to be considered at the AGM. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2022-12-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.